MYL, AVNR and ACT -- Pre-Market Briefing

The Dow Jones and the S&P 500 finished at multi-year highs on Tuesday. The Dow Jones closed 0.39% higher at 14,035.67, the S&P 500 closed 0.73% higher at 1,530.94, and the NASDAQ closed 0.68% higher at 3,213.59. At the close, our research team took notice of Mylan Inc. (NASDAQ: MYL), Avanir Pharmaceuticals (NASDAQ: AVNR) and Actavis Inc. (NYSE: ACT). Wall Street Active research team has completed free research on MYL, AVNR and ACT. As a leading provider of free in depth reports and timely market updates, we invite you to sign up now at
http://www.wallstreetactive.com/register.php
Mylan's Shares Slip
Mylan's shares fell on Tuesday, ending the day 0.38% lower at $29.11 on volume of 2.99 million. The stock rose to a 52-week high of $29.30 before paring its gains. The company's shares have had a decent run so far this year, gaining more than 6% as compared to a gain of around 6.4% for NASDAQ. Mylan's shares recently broke through $29 resistance level, which is a bullish signal. The bullish trend is further confirmed by the recent volume activity and its MACD chart. The stock's MACD is trading above the signal line and the zero-line. Mylan's share are trading above their 50-day and 200-day moving averages, which is another bullish signal. Sign up today and get useful insight about MYL for free at
http://www.wallstreetactive.com/register.php
Avanir Pharma's Shares Gain
Shares of Avanir Pharma, which is engaged in the development and commercialization of therapeutic products for the treatment of central nervous system disorders, rose sharply on Tuesday, ending the day 2.14% higher at $2.86 on volume of 1.07 million. The stock has had a decent run this year, gaining more than 9%. Avanir's shares are trading at their 50-day moving average and slightly below their 200-day moving average. The stock's MACD is currently trading below the signal line and the zero-line. The company's shares are currently facing resistance at around $3.20. The stock has support at $2.80. Free report on AVNR can be accessed by registering at
http://www.wallstreetactive.com/register.php
Actavis Shares End Marginally Lower
Actavis shares finished marginally lower on Tuesday. The stock closed 0.50% lower at $84.81 on above average volume of 2.06 million. Year-to-date, the company's shares have fallen more than 1.3%. The stock has been extremely volatile in recent weeks. It has been facing stiff resistance at around $88. Recent volume activity suggests that the market sentiment is bearish on the stock. The bearish trend is further confirmed by the MACD chart. The stock's MACD has just moved below the signal line and the zero-line. Register with Wall Street Active and download the research on ACT for free at
http://www.wallstreetactive.com/register.php
Disclaimer: WSA Financial is not a registered investment advisor, and nothing in this release is intended as a solicitation to buy or sell any security. Our pro-traders only aim is to educate investors based on their experience, and to share their knowhow.

Contact Person:
Ravi S. Kapur
Telecommunication, Information & Data Manager
info@wallstreetactive.com

Source:
MYL, AVNR and ACT -- Pre-Market Briefing

See also:

OSC Approves Release of Academy's Shares from Escrow
ACADEMY EXPLORATIONS LIMITED ("Academy" or the "Company"). On August 31, 2012, the Ontario Securities Commission approved the Company's request in Ontario to amend an existing escrow agreement among...

Danbel Ventures Appoints Ernst & Young LLP as Auditors
Danbel Ventures Inc. ("Danbel" or the "Company") is pleased to announce the appointment of Ernst & Young LLP ("E&Y") as its auditors, replacing Collins Barrow Toronto LLP ("Collins Barrow")....

Global Food Exchange and IFS Fund Announces Its Founders Will Be Presenting at the Accredited Members Spring Micro Cap Investor Conference in Las Vegas
Global Food Exchange Founder, Richard Lackey, and IFS Fund Founder, John Schiffner, will be presenting at the Accredited Members Spring Small Cap/Micro Cap Conference, being held at the JW Marriott...